MedTrace Logo

TURKish Acute Myocardial Infarction Registry

NCT04241770 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1930

Last updated 2020-02-05

No results posted yet for this study

Summary

There is no up-to-date information regarding presentation, management and clinical course of patients with acute myocardial infarction (MI) in Turkey. TURKMI registry is designed to provide insight to the characteristics, management from symptom onset to the hospital discharge and outcome of patients with acute MI in Turkey.

Conditions

  • Acute Myocardial Infarction

Interventions

OTHER

no intervention

no intervention

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY

  • Turkish Society of Cardiology

    lead OTHER

Principal Investigators

  • MUSTAFA K EROL, prof · Istanbul Private Sisli International Kolan Hospital,

  • MERAL KAYIKCIOGLU, prof · Ege University School of Medicine Department of Cardiology

  • MUSTAFa KILICKAP, prof · ANKARA University School of Medicine Department of Cardiology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2022-12-01
Completion
2023-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04241770 on ClinicalTrials.gov